Hub71 Launches Life Sciences Ecosystem to Accelerate Health Innovation
Abu Dhabi Strengthens Its Position as a Global Life Sciences Hub
Hub71, Abu Dhabi’s global tech ecosystem, has introduced Hub71+ Life Sciences, a specialist platform designed to drive innovation across BioTech, MedTech, and digital health. The initiative aims to accelerate the development and commercialization of health technologies while positioning Abu Dhabi as a global launchpad for life sciences founders. Through this new ecosystem, startups will gain direct access to a powerful network of regulators, hospitals, investors, and industry partners, helping them scale faster and more efficiently.
Connecting Founders with Abu Dhabi’s Integrated Health Cluster
Announced during Hub71’s annual Impact Event, Hub71+ Life Sciences provides founders with entry into Abu Dhabi’s advanced medical innovation ecosystem. From early clinical validation to market access, the platform supports startups through every stage of growth. The initiative aligns strategically with the Department of Health – Abu Dhabi (DoH), the Emirates Drug Establishment (EDE), and the HELM cluster, ensuring unified efforts to build a robust life sciences economy. Additionally, the growing MENA healthcare market—projected to reach $412 billion by 2032—demonstrates the region’s increasing focus on health innovation.
Driving Collaboration and Growth in HealthTech
Supported by anchor partners such as the Abu Dhabi Early Childhood Authority (ECA), Cleveland Clinic Abu Dhabi, and Ultrahuman, the ecosystem promotes collaboration between 12 key partners. Together, they will explore investment opportunities and help startups bring transformative innovations to market. Furthermore, existing startups like BioSapien, Ovasave, and Biotwin exemplify how Abu Dhabi’s infrastructure and research capabilities are advancing breakthroughs in oncology, fertility, and AI-driven medicine.
Hub71+ Life Sciences encourages startups in BioTech, MedTech, and digital health to apply and join a growing community focused on translating scientific discovery into global healthcare impact. By fostering cooperation among regulators, investors, and innovators, the initiative strengthens partnerships, accelerates clinical progress, and reinforces Abu Dhabi’s position as a leading hub for medical innovation.
